5-143400772-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000176.3(NR3C1):​c.68G>A​(p.Arg23Lys) variant causes a missense change. The variant allele was found at a frequency of 0.024 in 1,614,144 control chromosomes in the GnomAD database, including 590 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 42 hom., cov: 32)
Exomes 𝑓: 0.025 ( 548 hom. )

Consequence

NR3C1
NM_000176.3 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.77
Variant links:
Genes affected
NR3C1 (HGNC:7978): (nuclear receptor subfamily 3 group C member 1) This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a modified_residue Omega-N-methylarginine (size 0) in uniprot entity GCR_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.0039635897).
BP6
Variant 5-143400772-C-T is Benign according to our data. Variant chr5-143400772-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 351377.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-143400772-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0166 (2535/152312) while in subpopulation NFE AF= 0.0274 (1863/68038). AF 95% confidence interval is 0.0263. There are 42 homozygotes in gnomad4. There are 1168 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 42 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR3C1NM_000176.3 linkc.68G>A p.Arg23Lys missense_variant Exon 2 of 9 ENST00000394464.7 NP_000167.1 P04150-1F1D8N4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR3C1ENST00000394464.7 linkc.68G>A p.Arg23Lys missense_variant Exon 2 of 9 1 NM_000176.3 ENSP00000377977.2 P04150-1

Frequencies

GnomAD3 genomes
AF:
0.0166
AC:
2533
AN:
152194
Hom.:
42
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00456
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00621
Gnomad ASJ
AF:
0.0184
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.0208
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0274
Gnomad OTH
AF:
0.0124
GnomAD3 exomes
AF:
0.0183
AC:
4603
AN:
251468
Hom.:
55
AF XY:
0.0191
AC XY:
2595
AN XY:
135910
show subpopulations
Gnomad AFR exome
AF:
0.00443
Gnomad AMR exome
AF:
0.00676
Gnomad ASJ exome
AF:
0.0200
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0152
Gnomad FIN exome
AF:
0.0243
Gnomad NFE exome
AF:
0.0263
Gnomad OTH exome
AF:
0.0181
GnomAD4 exome
AF:
0.0248
AC:
36197
AN:
1461832
Hom.:
548
Cov.:
32
AF XY:
0.0245
AC XY:
17834
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.00355
Gnomad4 AMR exome
AF:
0.00720
Gnomad4 ASJ exome
AF:
0.0195
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0152
Gnomad4 FIN exome
AF:
0.0223
Gnomad4 NFE exome
AF:
0.0283
Gnomad4 OTH exome
AF:
0.0202
GnomAD4 genome
AF:
0.0166
AC:
2535
AN:
152312
Hom.:
42
Cov.:
32
AF XY:
0.0157
AC XY:
1168
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.00455
Gnomad4 AMR
AF:
0.00621
Gnomad4 ASJ
AF:
0.0184
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0143
Gnomad4 FIN
AF:
0.0208
Gnomad4 NFE
AF:
0.0274
Gnomad4 OTH
AF:
0.0123
Alfa
AF:
0.0228
Hom.:
120
Bravo
AF:
0.0149
TwinsUK
AF:
0.0270
AC:
100
ALSPAC
AF:
0.0304
AC:
117
ESP6500AA
AF:
0.00431
AC:
19
ESP6500EA
AF:
0.0285
AC:
245
ExAC
AF:
0.0178
AC:
2165
Asia WGS
AF:
0.00751
AC:
26
AN:
3478
EpiCase
AF:
0.0253
EpiControl
AF:
0.0254

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Glucocorticoid resistance Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

NR3C1-related disorder Benign:1
Jul 17, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.31
T;T;.;.;.;.;.;T;T;T;T;T;T
Eigen
Benign
0.044
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.58
.;T;T;T;.;.;T;.;.;.;.;T;T
MetaRNN
Benign
0.0040
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Benign
1.8
L;L;L;L;L;L;L;L;.;.;.;.;.
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.22
N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.14
Sift
Benign
0.035
D;D;D;D;D;D;D;D;T;T;T;T;T
Sift4G
Benign
0.98
T;T;T;T;T;T;T;T;.;.;.;.;T
Polyphen
0.29
B;B;.;.;.;.;.;B;.;.;.;.;.
Vest4
0.14
MPC
0.055
ClinPred
0.018
T
GERP RS
5.2
Varity_R
0.18
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6190; hg19: chr5-142780337; COSMIC: COSV99039780; API